Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Applovin Stock Falls Despite Q4 Earnings And Revenue Beat (Benzinga) +++ APPLOVIN Aktie -9,52%

BAXTER Aktie

 >BAXTER Aktienkurs 
16.544 EUR    -11.9%    (TradegateBSX)
Ask: 16.676 EUR / 1800 Stück
Bid: 16.57 EUR / 1850 Stück
Tagesumsatz: 2571 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
BAXTER Aktie über LYNX handeln
>BAXTER Performance
1 Woche: +6,1%
1 Monat: +3,5%
3 Monate: +20,5%
6 Monate: -6,7%
1 Jahr: -36,7%
laufendes Jahr: +15,4%
>BAXTER Aktie
Name:  BAXTER INTL DL 1
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US0718131099 / 853815
Symbol/ Ticker:  BTL (Frankfurt) / BAX (NYSE)
Kürzel:  FRA:BTL, ETR:BTL, BTL:GR, NYSE:BAX
Index:  S&P500
Webseite:  http://www.baxter.com/
Profil:  Baxter International Inc. is a leading global heal..
>Volltext..
Marktkapitalisierung:  9387.35 Mio. EUR
Unternehmenswert:  16178.04 Mio. EUR
Umsatz:  9263.45 Mio. EUR
EBITDA:  1455.53 Mio. EUR
Nettogewinn:  -222.7 Mio. EUR
Gewinn je Aktie:  -0.44 EUR
Schulden:  8161.72 Mio. EUR
Liquide Mittel:  1450.49 Mio. EUR
Operativer Cashflow:  629.44 Mio. EUR
Bargeldquote:  0.46
Umsatzwachstum:  -25.23%
Gewinnwachstum:  -316.76%
Dividende je Aktie:  0.45 EUR
Dividendenrendite:  2.39%
Dividendenschätzung:  0.18%
Div. Historie:  28.11.25 - 0.008618999€
29.08.25 - 0.14586€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  BAXTER, BAXTER INTL, (NYSE:BAX), NYSE:BAX, NYSE BAX
Letzte Datenerhebung:  12.02.26
>BAXTER Kennzahlen
Aktien/ Unternehmen:
Aktien: 514.06 Mio. St.
Frei handelbar: 99.56%
Rückkaufquote: -0.3%
Mitarbeiter: 38000
Umsatz/Mitarb.: 0.24 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 2.14%
Bewertung:
KGV: -
KGV lG: 8.99
KUV: 0.93
KBV: 1.51
PEG-Ratio: -
EV/EBITDA: 11.11
Rentabilität:
Bruttomarge: 34.65%
Gewinnmarge: -3.22%
Operative Marge: 6.77%
Managementeffizenz:
Gesamtkaprendite: -1.49%
Eigenkaprendite: -4.7%
 >BAXTER Anleihen 
>BAXTER Peer Group
Gesundheit
 
12.02.26 - 14:06
Baxter Int′l Provides Weak FY26 Outlook As Q4 Adj. EPS Misses Estimates; Stock Tumbles 14.6% (AFX)
 
DEERFIELD (dpa-AFX) - Health care company Baxter International, Inc. (BAX) reported Thursday a net loss attributable to shareholders for the fourth quarter of $1.12 billion or $2.19 per share, sha......
12.02.26 - 13:42
Baxter shares plunge 14% after earnings miss, weak profit guidance (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
12.02.26 - 13:42
Baxter forecast 2026 profit below estimates (Reuters EN)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
12.02.26 - 13:21
Baxter Non-GAAP EPS of $0.44 misses by $0.10, revenue of $2.97B beats by $150M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
12.02.26 - 13:21
Baxter Reports Fourth-Quarter 2025 Results (Business Wire)
 
Fourth-quarter sales from continuing operations of $2.97 billion increased 8% on a reported basis and 3% on an operational basis1,2 Fourth-quarter U.S. GAAP3 diluted earnings per share (EPS) (loss) from continuing operations of ($2.01); adjusted diluted EPS from continuing operations of $0.44 Company advances ongoing board of directors refreshment DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter of 2025. “While we delivered sales growth across all segments, our fourth-quarter results did not meet our expectations, underscoring the importance of our focus on driving continuous improvement across the enterprise,” said Andrew Hider, president and CEO. “We recently introduced a new operating model that is designed to simplify our organization, accelerate innovation and improve performance. These changes further decentralize the business and embed critical functional roles directly within each division – bring...
11.02.26 - 16:42
Baxter Q4 2025 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
10.02.26 - 21:15
Baxter to Post Q4 Earnings: What′s in Store for the Stock? (Zacks)
 
BAX's fourth-quarter results are likely to reflect muted revenue growth and an EPS decline due to ongoing infusion therapy and IV fluid headwinds....
10.02.26 - 16:45
Seeking Clues to Baxter (BAX) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
 
Beyond analysts' top-and-bottom-line estimates for Baxter (BAX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2025....
09.02.26 - 14:15
Savaria completes acquisition of Baxter Residential Elevators (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
06.02.26 - 16:48
Is Baxter International an Underrated Healthcare Investment Play? (Fool)
 
Baxter International is in turnaround mode, but a recent dividend decision will keep many investors away....
28.01.26 - 16:00
Reasons to Retain Baxter International Stock in Your Portfolio Now (Zacks)
 
BAX is reshaping its portfolio following the divestiture of its Kidney Care business, focusing on surgical strength, deleveraging and tighter execution to rebuild momentum....
21.01.26 - 23:03
Baxter to Host Fourth-Quarter 2025 Financial Results Conference Call for Investors (Business Wire)
 
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its fourth-quarter 2025 financial results on Thursday, February 12, 2026 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I81994118 to pre-register for the call and receive the call information. This call is also being webcast and can be accessed through Baxter's website at www.baxter.com. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter's permission. About Baxter At Baxter, we are everywhere healthcare happens – and everywhere it is going, with essential solutions in the hospital, physician's office and other sites of care. For nearly a century, our customers have counted on us as a vital and trusted partner. And every day, millions of patients and healthcare providers rely on our unmatched portfolio o...
19.01.26 - 14:18
What You Need To Know Ahead of Baxter International's Earnings Release (Barchart)
 
Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...
14.01.26 - 18:15
Baxter Unveils Dynamo Smart Stretcher to Improve Hospital Safety (Zacks)
 
BAX introduces its Dynamo Series smart stretcher, aiming to boost hospital safety and reduce patient transfers....
26.12.25 - 15:15
Reasons to Retain Baxter International Stock in Your Portfolio Now (Zacks)
 
BAX is reshaping its portfolio following the divestiture of Kidney Care, focusing on surgical strength, deleveraging and tighter execution to rebuild momentum....
19.12.25 - 15:12
IN BRIEF: Galliford Try executive sells PS260,000 in shares (Alliance)
 
Galliford Try Holdings PLC - Uxbridge, London-based construction firm - Kristen Baxter, an associate of Mark Baxter, managing...
15.12.25 - 18:15
BAX Highlights EMR-Integrated Smart Pumps Boost Patient Safety & Care (Zacks)
 
Baxter shows EMR-integrated smart pumps cut safety alerts and speed IV setup, backed by real-world data from over a million infusions at ASHP 2025....
15.12.25 - 08:12
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Baxter International Inc. with Losses of $100,000 to Contact the Firm (PR Newswire)
 
LOS ANGELES, Dec. 15, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Baxter International Inc. ("Baxter" or "the Company") (NYSE: BAX) for violations of §§10(b) and 20(a) of the Securities......
14.12.25 - 01:00
Beware airport parking thieves: police warn over spate of car thefts (The Guardian)
 
Drivers also told to take caution after complaints rise about long-stay meet-and-greet servicesTerence Baxter* had booked a meet-and-greet service to park his Volkswagen at Heathrow airport while he and his wife went on holiday. The couple handed over the keys at the drop-off site and were driven to the terminal – and that was the last they saw of their car. On their return they were informed by the company it had been stolen.Their case comes as airports and police forces are warning travellers to be wary of “unofficial” operators advertising cheap long-stay parking after a rise in complaints. Continue reading......
12.12.25 - 17:06
BAX DEADLINE: Faruqi & Faruqi Reminds Baxter Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 12, 2025 - BAX (PR Newswire)
 
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Baxter between February 23, 2022 and October 29, 2025 and would like to......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Mag alles Leid und Schatten sein - doch diese süße Sonnenstunde nicht, und nicht der Duft vom roten Klee, und nicht das tiefe, zarte Wohlgefühl in meiner Seele. - Hermann Hesse
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!